These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7554462)

  • 1. Interaction of antigenic peptides with MHC and TCR molecules.
    Sette A; Alexander J; Grey HM
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S168-71. PubMed ID: 7554462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen analogs/MHC complexes as specific T cell receptor antagonists.
    Sette A; Alexander J; Ruppert J; Snoke K; Franco A; Ishioka G; Grey HM
    Annu Rev Immunol; 1994; 12():413-31. PubMed ID: 8011286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events.
    Ruppert J; Alexander J; Snoke K; Coggeshall M; Herbert E; McKenzie D; Grey HM; Sette A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2671-5. PubMed ID: 8464874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide.
    Petersen TR; Bettelli E; Sidney J; Sette A; Kuchroo V; Bäckström BT
    Eur J Immunol; 2004 Jan; 34(1):165-73. PubMed ID: 14971042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide.
    Vessey SJ; Barouch DH; McAdam SN; Tussey LG; Davenport MA; O'Callaghan CA; Bell JI; McMichael AJ; Jakobsen BK
    Eur J Immunol; 1997 Apr; 27(4):879-85. PubMed ID: 9130639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands.
    Kersh GJ; Allen PM
    J Exp Med; 1996 Oct; 184(4):1259-68. PubMed ID: 8879197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic Origins of T Cell Receptor Alloreactivity.
    Brzostek J; Gascoigne NRJ
    Transplantation; 2017 Jul; 101(7):1535-1541. PubMed ID: 28114168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation.
    Campanelli R; Palermo B; Garbelli S; Mantovani S; Lucchi P; Necker A; Lantelme E; Giachino C
    Int Immunol; 2002 Jan; 14(1):39-44. PubMed ID: 11751750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen analogs as tools to study T-cell activation function and activation.
    Sette A; Alexander J; Snoke K; Grey HM
    Semin Immunol; 1996 Apr; 8(2):103-8. PubMed ID: 8920244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands.
    Alam SM; Davies GM; Lin CM; Zal T; Nasholds W; Jameson SC; Hogquist KA; Gascoigne NR; Travers PJ
    Immunity; 1999 Feb; 10(2):227-37. PubMed ID: 10072075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the strength of ligand antagonism in TCR triggering.
    Van Den Berg HA; Burroughs NJ; Rand DA
    Bull Math Biol; 2002 Jul; 64(4):781-808. PubMed ID: 12216421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low affinity interaction of peptide-MHC complexes with T cell receptors.
    Matsui K; Boniface JJ; Reay PA; Schild H; Fazekas de St Groth B; Davis MM
    Science; 1991 Dec; 254(5039):1788-91. PubMed ID: 1763329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A signal integration model of thymic selection and natural regulatory T cell commitment.
    Khailaie S; Robert PA; Toker A; Huehn J; Meyer-Hermann M
    J Immunol; 2014 Dec; 193(12):5983-96. PubMed ID: 25392533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of protein tyrosine kinases and their phosphorylation in murine Th1 cells anergized with class II MHC-peptide complexes.
    Yu SC; Nag B
    Immunol Cell Biol; 1997 Jun; 75(3):295-302. PubMed ID: 9243296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could TCR antagonism explain associations between MHC genes and disease?
    Vukmanović S; Neubert TA; Santori FR
    Trends Mol Med; 2003 Apr; 9(4):139-46. PubMed ID: 12727139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.
    Lanzarotti E; Marcatili P; Nielsen M
    Mol Immunol; 2018 Feb; 94():91-97. PubMed ID: 29288899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor (TCR) antagonism without a negative signal: evidence from T cell hybridomas expressing two independent TCRs.
    Stotz SH; Bolliger L; Carbone FR; Palmer E
    J Exp Med; 1999 Jan; 189(2):253-64. PubMed ID: 9892608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell receptor peptide-MHC interactions: biological lessons from structural studies.
    Garcia KC; Teyton L
    Curr Opin Biotechnol; 1998 Aug; 9(4):338-43. PubMed ID: 9720260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.